Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts novelty seeking and harm avoidance.
- DOI
- 10.1038/npp.2010.55
- Published
- 2010 Aug
- Container
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/npp.2010.55,
title = {Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts novelty seeking and harm avoidance.},
author = {Montag C and Markett S and Basten U and Stelzel C and Fiebach C and Canli T and Reuter M},
year = {2010},
journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
doi = {10.1038/npp.2010.55},
url = {https://doi.org/10.1038/npp.2010.55}
}RIS
TY - JOUR TI - Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts novelty seeking and harm avoidance. AU - Montag C AU - Markett S AU - Basten U AU - Stelzel C AU - Fiebach C AU - Canli T AU - Reuter M PY - 2010 JO - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology DO - 10.1038/npp.2010.55 UR - https://doi.org/10.1038/npp.2010.55 ER -
APA
C, M., S, M., U, B., C, S., C, F., T, C., & M, R. (2010). Epistasis of the DRD2/ANKK1 Taq Ia and the BDNF Val66Met polymorphism impacts novelty seeking and harm avoidance.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. https://doi.org/10.1038/npp.2010.55
Source records
- pubmed · retrieved 2026-09-25T04:49:30.315Z